user-avatar
Arnne Carragie

Why Is Moderna (MRNA) Stock Up 4.07% Today, Oct 19? BofA Raises Price Target as Phase 3 Cancer Results Approach

Moderna (MRNA) rose 4.07% to $226.89 on October 19, 2026, as a recent Goldman Sachs price-target increase supported sentiment ahead of major clinical and financial checkpoints. This draft examines the evidence, risks, technical structure, and price levels traders should watch next.